text
stringlengths 15
247
|
|---|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Colon, colonoscopic biopsy;
Tubular adenoma with high grade dysplasia
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Colon, colonoscopic biopsy;
Tubular adenoma with high grade dysplasia
|
Colon, colonoscopic biopsy;
Adenocarcinoma, well differentiated
|
Colon, colonoscopic biopsy;
Adenocarcinoma, poorly differentiated
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Lung, biopsy;
Squamous cell carcinoma
|
Uterine cervix, punch biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Lung, biopsy;
Adenocarcinoma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 15%), tumor volume: 70%
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Lung, biopsy;
No evidence of malignancy or granuloma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated with mucinous component
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Colon, colonoscopic biopsy;
Chronic nonspecific inflammation
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, punch biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 90%), tumor volume: 10%
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2)
with glandular involvement
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Lung, biopsy;
Adenocarcinoma
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Rectum, colonoscopic mucosal resection;
Hyperplastic polyp
|
Colon, colonoscopic biopsy;
Adenocarcinoma, well differentiated
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Uterine cervix, colposcopic biopsy;
Invasive squamous cell carcinoma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, punch biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2)
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2)
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 70%
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Lung, biopsy;
Squamous cell carcinoma
|
Uterine cervix, colposcopic biopsy;
Invasive squamous cell carcinoma
|
Uterine cervix, punch biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2)
|
Lung, biopsy;
Squamous cell carcinoma
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Colon, colonoscopic biopsy;
Tubular adenoma with high grade dysplasia
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, well differentiated
|
Colon, colonoscopic biopsy;
Chronic active colitis
|
Colon, colonoscopic biopsy;
Adenocarcinoma, well differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 80%
|
Colon, colonoscopic mucosal resection;
Tubular adenoma with high grade dysplasia
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 25%), tumor volume: 70%
|
Uterine cervix, punch biopsy;
Invasive squamous cell carcinoma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2)
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 9 (4+5), grade group 5, tumor volume: 100%
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Lung, biopsy;
Squamous cell carcinoma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, poorly differentiated
|
Uterine cervix, punch biopsy;
Invasive squamous cell carcinoma
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, punch biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2)
|
Uterine cervix, colposcopic biopsy;
Chronic nonspecific cervicitis
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Colon, colonoscopic biopsy;
Tubular adenoma with low grade dysplasia
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 30%
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Lung, biopsy;
Squamous cell carcinoma
|
Lung, biopsy;
Adenocarcinoma
|
Uterine cervix, colposcopic biopsy;
Invasive squamous cell carcinoma
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
with glandular involvement
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Colon, colonoscopic biopsy;
Chronic nonspecific inflammation
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 40%), tumor volume: 5%
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 10%), tumor volume: 55%
|
Uterine cervix, punch biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 80%
|
Colon, colonoscopic biopsy;
Tubular adenoma with high grade dysplasia
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Colon, colonoscopic biopsy;
Tubular adenoma with high grade dysplasia
|
Uterine cervix, punch biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.